awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33415880-1DF40776-675D-4D12-9FC6-3B6085F9AD8D
Q33415880-1DF40776-675D-4D12-9FC6-3B6085F9AD8D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33415880-1DF40776-675D-4D12-9FC6-3B6085F9AD8D
A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors.
P2860
Q33415880-1DF40776-675D-4D12-9FC6-3B6085F9AD8D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33415880-1DF40776-675D-4D12-9FC6-3B6085F9AD8D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3fdf2036dd7bdb31911c22f51c10fb11fd395984
P2860
Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges.